Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Sunday, November 23 2014 6:16am ET - U.S. Markets Closed.
Industry Center
Industry Center > > Silence Therapeutics plc Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Silence Therapeutics plc Company Profile
Silence Therapeutics wants to put the kibosh on disease-causing genes. The company works in the field of RNA interference (RNAi), a cutting-edge approach to treating disease that involves interfering with, or silencing, targeted genes associated with disease. Its AtuPLEX drug delivery system is designed to work specifically with RNA molecules. Silence Therapeutics acquired fellow RNAi research company Intradigm in 2010, greatly expanding its RNAi program capabilities, which it hopes will make it a more attractive partner to bigger pharmaceutical companies looking to develop products based on that science.
Contact Information
Address: The Royal Institute of Great Britain, 21 Albemarle Street
London W1S 4BS, United Kingdom
Phone:+44-207-491-6520
Fax:
Financial Highlights
Fiscal Year End:December
Revenue (2013):0.20 M
Revenue Growth (1 yr):(-26.70%)
Employees (2013):30
Employee Growth (1 yr):15.40%
Key People
Chairman: Simon Sturge
CEO: Ali Mortazavi
Finance Director and Secretary: Tim Freeborn
Industry Information
Sector:
Industry:
Top Competitors
Alnylam Pharmaceuticals, Inc. (alny)
Genentech, Inc.
Opko Health, Inc. (opk)
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?